Neogenomics (NEO) Change in Inventory (2010 - 2026)

Neogenomics (NEO) has reported Change in Inventory for 17 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

• Change in Inventory for Q1 2026 came in at $1.3 million, down 57.97% year-over-year; the trailing twelve-month figure through Mar 2026 was -$210000.0 (down 102.2% YoY), and the FY2025 annual result was $1.5 million, down 42.83% from the prior year.
• Change in Inventory was $1.3 million for Q1 2026 at Neogenomics, up from $28000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $4.1 million in Q2 2025 and troughed at -$5.6 million in Q3 2025.
• Average Change in Inventory over 5 years is $415705.9, with a median of $688000.0 recorded in 2023.
• The widest YoY moves for Change in Inventory: up 1034.16% in 2024, down 2018.0% in 2024.
• Over 5 years, Change in Inventory stood at $697000.0 in 2022, then slumped by 71.02% to $202000.0 in 2023, then soared by 1034.16% to $2.3 million in 2024, then slumped by 98.78% to $28000.0 in 2025, then soared by 4439.29% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $1.3 million in Q1 2026, $28000.0 in Q4 2025, and -$5.6 million in Q3 2025.